Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 2Breast Neoplasms 2Acrocephalosyndactylia 2Uterine Cervical Neoplasms 1Tumor With Alterations of the FGF-R 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Cholangiocarcinoma 1

Interventions

infigratinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Tumor With Alterations of the FGF-R × infigratinib × Clear all
NCT01697605 2020-12-08

A Phase I Study of Oral BGJ398 in Asian Patients

Novartis

Phase 1 Completed
9 enrolled

Tumor With Alterations of the FGF-R

Data powered by HemOnc (CC BY 4.0) Colophon âš¡